Rural job scheme guarantees carbon sequestration mongabay.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from mongabay.com Daily Mail and Mail on Sunday newspapers.
Rare blood clot disorder among people who received J&J vaccine
Reversing over the month-long trend, new Covid cases in Karnataka declined to 35,297 in a day, while deaths due to the infection reduced to 344 during the day, said the state health bulletin on Thursday. Against 39,998 positive cases on Tuesday, new cases registered on Wednesday declined to 35,297, taking the state s Covid tally of cases to 20,88,488, including 5,93,078 active cases, while recoveries rose to 14,74,678, with 34,057 discharged in the last 24 hours, said the bulletin.
SARS-CoV-2 (Representational Picture)Pixabay
As epi-centre of the pandemic in the state, Bengaluru reported 15,191 fresh cases, taking its Covid tally of cases to 10,14,996, including 3,59,565 active cases, while 6,46,305 recovered, with 16,084 discharged during the day.
CoWin shows vaccination successful without giving jab
The premier Bengaluru-based Indian Institute of Science (IISc) is developing a Covid vaccine, informed Karnataka Health Minister K. Sudhakar on Thursday, which has reportedly proven to be more successful than existing vaccines.
The IISc vaccine has reportedly shown a more significant neutralising effect than existing vaccines like Covishield or Covaxin and it can be stored at a room temperature of up to 30 degrees.
According to the IISC website, vaccine production would cost Rs. 15 crore. The aim is to create a vaccine that can be mass-produced quickly to protect frontline health workers, medical staff, senior citizens, and people with co-morbidities like cardiovascular diseases and diabetes.
IISc developing oxygen concentrator, vaccine for Covid patients
By IANS |
Published on
Thu, May 13 2021 21:42 IST |
48 Views
Indian Institute of Science (IISc). (File Photo: IANS). Image Source: IANS News
Bengaluru, May 13 : The premier Bengaluru-based Indian Institute of Science (IISc) is developing a low-cost oxygen concentrator and anti-Covid vaccine, Karnataka Health Minister K. Sudhakar said on Thursday. IISc researchers are designing a low-cost and efficient oxygen concentrator and developing a vaccine for treating Covid patients, said Sudhakar after a virtual interaction with the state-run institute s Director Govindan Rangarajan.
The institute s prototype oxygen concentrator of 10 litres per minute (LPM) capacity is being tested for clinical validation at the Bangalore Medical College.